The MMR deficiency is often associated with promoter methylation and inflammation, especially the promoter methylation of MLH110,11,39, But further research is needed to determine whether NF-κB affect MMR promoter methylation through inflammatory pathways, thereby affecting tumor dMMR status. This evidence concerns the gene MRC1 and neoplasm.